DNA damage-induced heterogeneous nuclear ribonucleoprotein K SUMOylation regulates p53 transcriptional activation

Journal of Biological Chemistry

Volumn 287, Issue 36, 2012, Pages 30789-30799

  Pelisch, Federico ^a   Pozzi, Berta ^a   Risso, Guillermo ^a   Muñoz, Manuel Javier ^a   Srebrow, Anabella ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CO-ACTIVATION; COFACTORS; DNA DAMAGE RESPONSE; DNA DAMAGES; E3 LIGASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN (HNRNP); NUCLEAR RIBONUCLEOPROTEIN; NUCLEO-CYTOPLASMIC SHUTTLING; POST-TRANSLATIONAL MODIFICATIONS; SHARP CONTRAST; SUMO CONJUGATION; SUMOYLATION; TARGET GENES; TRANSCRIPTIONAL ACTIVATIONS; UBIQUITIN;

AMINO ACIDS; GENES;

DNA;

DNA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; LYSINE; POLYCOMB GROUP PROTEIN; PROTEIN P53; SUMO PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; P21 GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UBIQUITINATION;

CELL LINE, TUMOR; DNA DAMAGE; HEK293 CELLS; HUMANS; POLYCOMB-GROUP PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RIBONUCLEOPROTEINS; SUMO-1 PROTEIN; SUMOYLATION; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 84865714994     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.390120     Document Type: Article

References (55)

1. Geiss-Friedlander, R., and Melchior, F. (2007) Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956
2. Hay, R. T. (2005) SUMO: a history of modification. Mol. Cell 18, 1-12
3. Bernassola, F., Karin, M., Ciechanover, A., and Melino, G. (2008) The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14, 10-21
4. Deshaies, R. J., and Joazeiro, C. A. (2009) RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434
5. Kahyo, T., Nishida, T., and Yasuda, H. (2001) Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8, 713-718
6. Weger, S., Hammer, E., and Heilbronn, R. (2005) Topors acts as a SUMO-1E3 ligase for p53 in vitro and in vivo. FEBS Lett. 579, 5007-5012
7. Kagey, M. H., Melhuish, T. A., and Wotton, D. (2003) The polycomb protein Pc2 is a SUMO E3. Cell 113, 127-137
8. Pichler, A., Knipscheer, P., Saitoh, H., Sixma, T. K., and Melchior, F. (2004) The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type. Nat. Struct. Mol. Biol. 11, 984-991
9. Pichler, A., Gast, A., Seeler, J. S., Dejean, A., and Melchior, F. (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109-120
10. Yunus, A. A., and Lima, C. D. (2009) Structure of the Siz/PIAS SUMO E3 ligase Siz1 and determinants required for SUMO modification of PCNA. Mol. Cell 35, 669-682
11. Kagey, M. H., Melhuish, T. A., Powers, S. E., and Wotton, D. (2005) Multiple activities contribute to Pc2 E3 function. EMBO J. 24, 108-119
12. Werner, A., Flotho, A., and Melchior, F. (2012) The RanBP2/RanGAP1 *SUMO1/Ubc9 Complex Is a Multisubunit SUMO E3 Ligase. Mol. Cell 46, 287-298
13. Merrill, J. C., Melhuish, T. A., Kagey, M. H., Yang, S. H., Sharrocks, A. D., and Wotton, D. (2010) A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity. PLoS One 5, e8794
14. Ulrich, H. D. (2009) The SUMO system: an overview. Methods Mol. Biol. 497, 3-16
15. Garcia-Dominguez, M., and Reyes, J. C. (2009) SUMO association with repressor complexes, emerging routes for transcriptional control. Biochim. Biophys. Acta 1789, 451-459
16. Gill, G. (2005) Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15, 536-541
17. Zhao, J. (2007) Sumoylation regulates diverse biological processes. Cell Mol. Life Sci 64, 3017-3033
18. Girdwood, D., Bumpass, D., Vaughan, O. A., Thain, A., Anderson, L. A., Snowden, A. W., Garcia-Wilson, E., Perkins, N. D., and Hay, R. T. (2003) P300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11, 1043-1054
19. Shiio, Y., and Eisenman, R. N. (2003) Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. U.S.A. 100, 13225-13230
20. Yang, S. H., and Sharrocks, A. D. (2004) SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 13, 611-617
21. Guo, B., and Sharrocks, A. D. (2009) Extracellular signal-regulated kinase7 mitogen-activated protein kinase signaling initiates a dynamic interplay between sumoylation and ubiquitination to regulate the activity of the transcriptional activator PEA3. Mol. Cell Biol. 29, 3204-3218
22. Lyst, M. J., and Stancheva, I. (2007) A role for SUMO modification in transcriptional repression and activation. Biochem. Soc. Trans. 35, 1389-1392
23. Rosonina, E., Duncan, S. M., and Manley, J. L. (2010) SUMO functions in constitutive transcription and during activation of inducible genes in yeast. Genes Dev. 24, 1242-1252
24. Matunis, M. J., Michael, W. M., and Dreyfuss, G. (1992) Characterization and primary structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein. Mol. Cell Biol. 12, 164-171
25. Bomsztyk, K., Denisenko, O., and Ostrowski, J. (2004) hnRNP K: one protein multiple processes. Bioessays 26, 629-638
26. Moumen, A., Masterson, P., O'Connor, M. J., and Jackson, S. P. (2005) hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell 123, 1065-1078
27. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
28. Beckerman, R., and Prives, C. (2010) Transcriptional regulation by p53. Cold Spring Harb. Perspect. Biol. 2, a000935
29. Vousden, K. H., and Prives, C. (2009) Blinded by the Light: The Growing Complexity of p53. Cell 137, 413-431
30. Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann- Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., Attardi, L. D., Regev, A., Lander, E. S., Jacks, T., and Rinn, J. L. (2010) A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419
31. Li, T., Evdokimov, E., Shen, R. F., Chao, C. C., Tekle, E., Wang, T., Stadtman, E. R., Yang, D. C., and Chock, P. B. (2004) Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis. Proc. Natl. Acad. Sci. U.S.A. 101, 8551-8556
32. Bergink, S., and Jentsch, S. (2009) Principles of ubiquitin and SUMO modifications in DNA repair. Nature 458, 461-467
33. Cazalla, D., Sanford, J. R., and Cáceres, J. F. (2005) A rapid and efficient protocol to purify biologically active recombinant proteins from mammalian cells. Protein Expr. Purif. 42, 54-58
34. Pelisch, F., Gerez, J., Druker, J., Schor, I. E., Muñoz, M. J., Risso, G., Petrillo, E., Westman, B. J., Lamond, A. I., Arzt, E., and Srebrow, A. (2010) The serine/arginine-rich protein SF2/ASF regulates protein sumoylation. Proc. Natl. Acad. Sci. U.S.A. 107, 16119-16124
35. Tatham, M. H., Rodriguez, M. S., Xirodimas, D. P., and Hay, R. T. (2009) Detection of protein SUMOylation in vivo. Nat. Protoc. 4, 1363-1371
36. Gomes, N. P., Bjerke, G., Llorente, B., Szostek, S. A., Emerson, B. M., and Espinosa, J. M. (2006) Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev. 20, 601-612
37. Ren, J., Gao, X., Jin, C., Zhu, M., Wang, X., Shaw, A., Wen, L., Yao, X., and Xue, Y. (2009) Systematic study of protein sumoylation: Development of a site-specific predictor of SUMOsp 2.0. Proteomics 9, 3409-3412
38. Deleted in proof
39. Roscic, A., Möller, A., Calzado, M. A., Renner, F., Wimmer, V. C., Gresko, E., Lüdi, K. S., and Schmitz, M. L. (2006) Phosphorylation- dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol. Cell 24, 77-89
40. Yang, S. H., and Sharrocks, A. D. (2010) The SUMO E3 ligase activity of Pc2 is coordinated through a SUMO interaction motif. Mol. Cell Biol. 30, 2193-2205
41. Sacher, M., Pfander, B., Hoege, C., and Jentsch, S. (2006) Control of Rad52 recombination activity by double-strand break-induced SUMO modification. Nat. Cell Biol. 8, 1284-1290
42. Dou, H., Huang, C., Singh, M., Carpenter, P. B., and Yeh, E. T. (2010) Regulation of DNA repair through deSUMOylation and SUMOylation of replication protein A complex. Mol. Cell 39, 333-345
43. Galanty, Y., Belotserkovskaya, R., Coates, J., Polo, S., Miller, K. M., and Jackson, S. P. (2009) Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 462, 935-939
44. Morris, J. R., Boutell, C., Keppler, M., Densham, R., Weekes, D., Alamshah, A., Butler, L., Galanty, Y., Pangon, L., Kiuchi, T., Ng, T., and Solomon, E. (2009) The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462, 886-890
45. Puca, R., Nardinocchi, L., Givol, D., and D'Orazi, G. (2010) Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene 29, 4378-4387
46. Rinaldo, C., Prodosmo, A., Siepi, F., Moncada, A., Sacchi, A., Selivanova, G., and Soddu, S. (2009) HIPK2 regulation by MDM2 determines tumor cell response to the p53-reactivating drugs nutlin-3 and RITA. Cancer Res. 69, 6241-6248
47. Rinaldo, C., Prodosmo, A., Mancini, F., Iacovelli, S., Sacchi, A., Moretti, F., and Soddu, S. (2007) MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol. Cell 25, 739-750
48. Di Stefano, V., Mattiussi, M., Sacchi, A., and D'Orazi, G. (2005) HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations. FEBS Lett. 579, 5473-5480
49. Rui, Y., Xu, Z., Lin, S., Li, Q., Rui, H., Luo, W., Zhou, H. M., Cheung, P. Y., Wu, Z., Ye, Z., Li, P., Han, J., and Lin, S. C. (2004) Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. EMBO J. 23, 4583-4594
50. Kang, X., Qi, Y., Zuo, Y., Wang, Q., Zou, Y., Schwartz, R. J., Cheng, J., and Yeh, E. T. (2010) SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. Mol. Cell 38, 191-201
51. Enge, M., Bao, W., Hedström, E., Jackson, S. P., Moumen, A., and Selivanova, G. (2009) MDM2-dependent downregulation of p21 and hnRNP Kprovides a switch between apoptosis and growth arrest induced by pharmacologically activated p53. Cancer Cell 15, 171-183
52. Yang, L., Lin, C., Liu, W., Zhang, J., Ohgi, K. A., Grinstein, J. D., Dorrestein, P. C., and Rosenfeld, M. G. (2011) ncRNA- and Pc2 methylation-depen dent gene relocation between nuclear structures mediates gene activation programs. Cell 147, 773-788
53. Beli, P., Lukashchuk, N., Wagner, S. A., Weinert, B. T., Olsen, J. V., Baskcomb, L., Mann, M., Jackson, S. P., and Choudhary, C. (2012) Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response. Mol. Cell 46, 212-225
54. Decorsière, A., Cayrel, A., Vagner, S., and Millevoi, S. (2011) Essential role for the interaction between hnRNP H/F and a G quadruplex in maintaining p53 pre-mRNA 3′-end processing and function during DNA damage. Genes Dev. 25, 220-225
55. Vassileva, M. T., and Matunis, M. J. (2004) SUMO modification of heterogeneous nuclear ribonucleoproteins. Mol. Cell Biol. 24, 3623-3632